Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adiponectin actions in the cardiovascular system.

Teresa A Hopkins1, Noriyuki Ouchi, Rei Shibata

  • 1Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.

Cardiovascular Research
|December 5, 2006
PubMed
Summary

Adiponectin, a hormone downregulated in obesity, offers protection against metabolic and cardiovascular diseases. This review explores its beneficial roles in conditions like heart disease and hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mosaic Loss-of-Y Chromosome in Men Is Associated With Aortic Enlargement But Not Aortic Stenosis.

JACC. Advances·2026
Same author

Transient efferocytosis-induced activation of IKKβ reprograms macrophages to promote tissue resolution.

bioRxiv : the preprint server for biology·2026
Same author

PCPE-1 promotes cardiac fibrosis with aging and obesity.

JCI insight·2026
Same author

Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast-like differentiation.

The Journal of clinical investigation·2026
Same author

Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure.

Immunological reviews·2026

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Syndrome

Background:

  • Obesity is linked to type 2 diabetes, hypertension, and cardiovascular disease.
  • Adiponectin hormone levels are reduced in obese individuals.
  • Adiponectin plays a protective role in obesity-related diseases.

Purpose of the Study:

  • To review epidemiological and experimental studies on adiponectin's role in cardiovascular diseases.
  • To elucidate the mechanisms by which adiponectin confers protection.
  • To highlight adiponectin's benefits in pathological cardiac remodeling and injury.

Main Methods:

  • Review of epidemiological data.
  • Analysis of experimental studies.
  • Examination of signaling pathways, including 5' AMP-activated protein kinase.

Related Experiment Videos

Main Results:

  • Adiponectin demonstrates protective effects against cardiovascular diseases.
  • It favorably impacts atherogenesis, endothelial function, and vascular remodeling.
  • Adiponectin benefits cardiac cells in pathological remodeling and acute injury.

Conclusions:

  • Adiponectin is a key hormone in mitigating cardiovascular risks associated with obesity.
  • Its activation of signaling cascades is crucial for its cardioprotective effects.
  • Further research into adiponectin's therapeutic potential is warranted.